mAbs can protect people from infection, worsening disease, and potential hospitalization.
For emergency use for those at risk of getting more serious symptoms or with high-risk COVID factors.
Covered by insurance/federal uninsured fund with no out-of-pocket cost
Monoclonal antibody therapy can reduce COVID-19 symptoms, hospitalization or emergency room visits when administered as soon as possible after exposure or within 10 days of symptom onset.
70%-85% reduction in hospitalization and death in patients
80% reduction of infection among patients’ households
This is an outpatient treatment, administered either intravenously or through injections. We offer this treatment free for qualifying individuals who have tested positive or been exposed to COVID-19.
Who is Eligible?
Approximately 85% of adult Americans who are exposed or test positive qualify for this treatment.
mAbs are authorized for use for people ages 12+, who have tested positive or been exposed to COVID-19 but are not hospitalized.
mAbs can protect people from infection, worsening disease, and potential hospitalization.
For emergency use for those at risk of getting more serious symptoms or with high-risk COVID factors.
Covered by insurance/federal uninsured fund with no out-of-pocket cost
Administered by IV (through a vein) or by injection, these outpatient COVID treatments have been shown to reduce hospitalization or emergency room visits when received early. They have also shown to reduce viral load and reduce days of symptoms. The are three authorized monoclonal antibody therapies. They are manufactured by Regeneron, Eli Lilly or Glaxo Smith Kline.
Who Can Receive Monoclonal Antibody Therapy?
These medicines are authorized for use for people age 12 and older, who have been exposed to COVID OR have tested positive for COVID-19 and who meet other specific criteria.
For more information about these treatments, the specific criteria and potential side effects, please read the Patient Fact Sheet (Regeneron, Eli Lilly or Glaxo Smith Kline).
Covid-19 Recovery in 5 Steps
Fill out Form
Fill out qualification form.
We Review
A doctor will review and recommend a course of treatment. mAbs are administered either by IV or injections.
Schedule Appointment
You will be contacted to schedule your appointment
mAbs Treatment
You’ll receive a home treatment visit. Receiving mAbs intravenously takes between 20-50 min, and injections take about 3 minutes. There is a 1 hour observation period following the treatment.
Very easy to work with and accomodating. He would show us houses we wanted to see and would point out the good things along with any possible issues that he saw.
He consistently looked out for my family's best interest when helping me find my home. I could not have asked for a better reakor. He was quick acting in a fast market. and his recommendations were always great. He was extremely kind and
Working with Imperial Properties Solution was a pleasure he kept me well informed on every step that took place and was very informative. Thank you once again and look forward to future dealings.
It is a long established fact that a reader will be distracted by the readable content of a page.